Dermatitis: all 1,425 studies

Page 4 of 15. Open to participants first (127), then studies with results posted, then the rest; newest registration first within each.

• Crisaborole Ointment 2% Skin Biomarker Biopsy Study in Atopic DermatitisCompletedNCT03233529Phase 2Results posted
• Tralokinumab Monotherapy for Moderate to Severe Atopic Dermatitis - ECZTRA 2 (ECZema TRAlokinumab Trial no. 2)CompletedNCT03160885Phase 3Results posted
• Evaluation of the Efficacy of an Autologous Microbiome Transplant in Adult Atopic Dermatitis PatientsCompletedNCT03158012Phase 1Results posted
• Targeted Microbiome Transplant in Atopic DermatitisCompletedNCT03151148Phase 1/2Results posted
• Tralokinumab Monotherapy for Moderate to Severe Atopic Dermatitis - ECZTRA 1 (ECZema TRAlokinumab Trial no. 1)CompletedNCT03131648Phase 3Results posted
• Bioequivalence Study of Pimecrolimus Cream, 1% and Elidel® Cream, 1% in Mild to Moderate Atopic DermatitisCompletedNCT03107611Phase 3Results posted
• Dose-ranging Study of Nemolizumab in Atopic DermatitisCompletedNCT03100344Phase 2Results posted
• Efficacy and Safety of IDP-124 Lotion for the Treatment of Moderate to Severe Atopic Dermatitis in Pediatric and Adult SubjectsCompletedNCT03058783Phase 3Results posted
• Efficacy and Safety Study of Mepolizumab in Subjects With Moderate to Severe Atopic DermatitisTerminatedNCT03055195Phase 2Results posted
• Evaluating Treatment Resistant Dermatitis TaroIIRCompletedNCT03050294Phase 4Results posted
• Phase 2 Study of OPA-15406 Ointment in Pediatric Patients With Atopic DermatitisCompletedNCT03018691Phase 2Results posted
• A Study to Evaluate the Safety and Efficacy of Ruxolitinib Phosphate Cream Applied Topically to Adults With Atopic DermatitisCompletedNCT03011892Phase 2Results posted
• Insulin Sensitivity in Patients With Atopic DermatitisCompletedNCT03003793Results posted
• Efficacy and Safety of IDP-124 Lotion for the Treatment of Moderate to Severe Atopic Dermatitis in Pediatric and Adult Subjects (301)CompletedNCT03002571Phase 3Results posted
• Study of the Efficacy, Safety, and Tolerability of Serlopitant for Pruritus (Itch) in Atopic DermatitisCompletedNCT02975206Phase 2Results posted
• Pharmacokinetics and Safety of MM36 Topical Ointment in Pediatric Subjects With Atopic DermatitisCompletedNCT02945657Phase 2Results posted
• An Open Label, Safety Study to Assess the Potential for Adrenal Suppression.CompletedNCT02932891Phase 2Results posted
• Safety and Efficacy Study of Topically Applied DS107 Cream in Mild to Moderate Atopic Dermatitis Patients (AD)CompletedNCT02925793Phase 2Results posted
• A Study to Evaluate ABT-494 (Upadacitinib) in Adults With Moderate to Severe Atopic DermatitisCompletedNCT02925117Phase 2Results posted
• Study of OPA-15406 Ointment in Patients With Atopic DermatitisCompletedNCT02914548Phase 2Results posted
• Topical NanoDox® for Atopic DermatitisCompletedNCT02910011Phase 2Results posted
• A Trial of a Botanical Drug Containing East Indian Sandalwood Oil (EISO) For Treatment of Atopic DermatitisCompletedNCT02871479Phase 2Results posted
• Efficacy and Safety Study of Orally Administered DS107 in Moderate to Severe Atopic Dermatitis PatientsCompletedNCT02864498Phase 2Results posted
• A Study to Determine the Safety & Efficacy of ZPL-5212372 in Healthy Subjects and in Subjects With Atopic DermatitisCompletedNCT02795832Phase 1/2Results posted
• Study of Equivalence of Generic Pimecrolimus Cream 1% and Elidel® 1% in Subjects With Mild to Moderate Atopic DermatitisCompletedNCT02791308Phase 3Results posted
• Study To Evaluate Pf-04965842 In Subjects With Moderate To Severe Atopic DermatitisCompletedNCT02780167Phase 2Results posted
• A Study to Assess the Efficacy and Safety of Dupilumab in Participants With Severe Atopic Dermatitis (AD) That Are Not Controlled With Oral Cyclosporine A (CSA) or for Those Who Cannot Take Oral CSA Because it is Not Medically AdvisableCompletedNCT02755649Phase 3Results posted
• Study Of PF-06817024 In Healthy Subjects, In Patients With Chronic Rhinosinusitis With Nasal Polyps And in Patients With Atopic DermatitisCompletedNCT02743871Phase 1Results posted
• A Clinical Evaluation of 3M Cavilon Advanced Barrier Film for the Treatment of Incontinence Associated Dermatitis (IAD)CompletedNCT02724449Not applicableResults posted
• Trial to Determine the Therapeutic Benefit of an OTC Cream on Dry, Itchy Skin of Adults and Children With EczemaCompletedNCT02691507Phase 2Results posted
• To Assess the Safety and Activity of GBR 830, Compared to Placebo, in Adults With Moderate-to-severe Atopic DermatitisCompletedNCT02683928Phase 2Results posted
• Topical Steroid Formulation and Wet WrapsCompletedNCT02680301Phase 4Results posted
• An Ascending Multiple Dose Study of VTP-38543 in Adult Participants With Mild to Moderate Atopic DermatitisCompletedNCT02655679Phase 1/2Results posted
• Tradipitant in Treatment-resistant Pruritus Associated With Atopic DermatitisCompletedNCT02651714Phase 2Results posted
• Clinical Evaluation of Metal Panel Allergens: Dose Response StudyCompletedNCT02615249Phase 2Results posted
• The Use of Coconut Oil for the Prevention and Treatment of Diaper Dermatitis in the NICU PopulationCompletedNCT02614248Not applicableResults posted
• Clinical Study to Evaluate the Efficacy and Safety of Desoximetasone (DSXS) With Atopic DermatitisCompletedNCT02595073Phase 3Results posted
• Study to Assess the Potential for Adrenal Suppression Following Treatment With DSXS in Patients With Atopic DermatitisCompletedNCT02595008Phase 2Results posted
• Secukinumab for Treatment of Atopic DermatitisCompletedNCT02594098Phase 2Results posted
• Cetaphil Restoraderm Effect on Young Children With Atopic DermatitisCompletedNCT02589392Not applicableResults posted
• A Study of Baricitinib (LY3009104) in Participants With Moderate-to-Severe Atopic DermatitisCompletedNCT02576938Phase 2Results posted
• Clinical Study to Assess a New Barrier Film's Ability to Provide Skin Protection Against Incontinence & Allow HealingTerminatedNCT02570139Not applicableResults posted
• A Dose-Finding Study of GSK2894512 Cream in Subjects With Atopic Dermatitis (AD)CompletedNCT02564055Phase 2Results posted
• Prophylactic Topical Agents in Reducing Radiation-Induced Dermatitis in Patients With Non-inflammatory Breast CancerCompletedNCT02556632Phase 2Results posted
• Topical Use of Difinsa53™ to Prevent Radiation DermatitisTerminatedNCT02534129Phase 1/2Results posted
• Phase 2a Study to Evaluate the Efficacy and Safety of MEDI9929 in Adults With Atopic DermatitisCompletedNCT02525094Phase 2Results posted
• A Study to Determine the Efficacy of ZPL-3893787 in Subjects With Atopic DermatitisCompletedNCT02424253Phase 2Results posted
• A Study to Determine the Safety and Tolerability of Dupilumab (REGN668/SAR231893) in Patients Aged ≥6 to <18 Years With Atopic Dermatitis (Eczema)CompletedNCT02407756Phase 2Results posted
• A Study to Confirm the Efficacy and Safety of Different Dupilumab Dose Regimens in Adults With Atopic Dermatitis (AD)CompletedNCT02395133Phase 3Results posted
• Modified Dakin's Solution in Reducing Radiation-Induced Dermatitis in Patients With Head and Neck Cancer Undergoing Radiation TherapyCompletedNCT02369835Phase 3Results posted
• Tolerance Evaluation of a Nighttime Moisturizing Balm on Babies and Adults With EczemaCompletedNCT02357940Not applicableResults posted
• Phase 2 Study to Evaluate the Efficacy and Safety of Tralokinumab in Adults With Atopic DermatitisCompletedNCT02347176Phase 2Results posted
• A Phase 1 Trial of OPA-15406 Ointment in Healthy Adult Male SubjectsCompletedNCT02334787Phase 1Results posted
• Pilot Efficacy and Safety Study of AQX-1125 in Atopic DermatitisCompletedNCT02324972Phase 2Results posted
• A Study to Determine Serum and Skin Biopsy Biomarkers in Patients Receiving Topical Corticosteroid (TCS) and Following TCS WithdrawalTerminatedNCT02317276Phase 4Results posted
• CeraVe Cream Compared to Desitin Paste for Treating Diaper Dermatitis in InfantsTerminatedNCT02299206Not applicableResults posted
• Oregano Ointment vs. Standard Treatment for Pediatric Atopic DermatitisTerminatedNCT02289989Not applicableResults posted
• Study of Dupilumab (REGN668/SAR231893) Monotherapy Administered to Adult Patients With Moderate-to-Severe Atopic DermatitisCompletedNCT02277769Phase 3Results posted
• Study of Dupilumab Monotherapy Administered to Adult Patients With Moderate-to-Severe Atopic DermatitisCompletedNCT02277743Phase 3Results posted
• Study to Assess the Efficacy and Long-term Safety of Dupilumab (REGN668/SAR231893) in Adult Participants With Moderate-to-Severe Atopic DermatitisCompletedNCT02260986Phase 3Results posted
• MediHoney for Radiation DermatitisCompletedNCT02234479Not applicableResults posted
• Oral DS107 in Moderate to Severe Atopic DermatitisCompletedNCT02211417Phase 2Results posted
• Study of Dupilumab and Immune Responses in Adults With Atopic Dermatitis (AD)CompletedNCT02210780Phase 2Results posted
• Dakin's Solution in Preventing Radiation Dermatitis in Patients With Breast Cancer Undergoing Radiation TherapyCompletedNCT02203565Phase 2Results posted
• RTA 408 Lotion in Patients at Risk for Radiation Dermatitis - PRIMROSECompletedNCT02142959Phase 2Results posted
• Safety and Efficacy of AN2728 Topical Ointment, 2% in Children, Adolescents, and Adults (Aged 2 Years and Older) With Atopic DermatitisCompletedNCT02118792Phase 3Results posted
• Safety and Efficacy of AN2728 Topical Ointment, 2% in Children, Adolescents, and Adults (Ages 2 Years and Older) With Atopic DermatitisCompletedNCT02118766Phase 3Results posted
• Efficacy and Safety Study of Apremilast in Subjects With Moderate to Severe Atopic DermatitisCompletedNCT02087943Phase 2Results posted
• A Study to Evaluate the Effectiveness and Safety of Topical OPA-15406 Ointment to Treat Participants With Atopic DermatitisCompletedNCT02068352Phase 2Results posted
• Clinical Evaluation of Metal Panel Allergens: Mercury, Aluminum and Palladium Dose Response StudyCompletedNCT02028208Phase 2Results posted
• Clinical Evaluation of Lyral® Dose Response StudyCompletedNCT02028182Phase 2Results posted
• Proof of Concept of VLY-686 in Subjects With Treatment-Resistant Pruritus Associated With Atopic DermatitisCompletedNCT02004041Phase 2Results posted
• Effect of OC000459 on Moderate to Severe Atopic DermatitisCompletedNCT02002208Phase 2Results posted
• Tofacitinib Ointment For Atopic Dermatitis (Atopic Eczema)CompletedNCT02001181Phase 2Results posted
• Photocil (Topical) for the Treatment of Atopic DermatitisCompletedNCT01992172Not applicableResults posted
• A Phase 2 Study of CIM331 for Atopic Dermatitis PatientsCompletedNCT01986933Phase 2Results posted
• Study to Determine the Safety and Effectiveness of Dupilumab for Treatment of Atopic Dermatitis (AD)CompletedNCT01979016Phase 2Results posted
• Validation of the Short-term Antimicrobial Action of Transplanted BacteriaCompletedNCT01959113Phase 1Results posted
• A Study of Ustekinumab (STELARA®) in Adult Japanese Participants With Severe Atopic DermatitisCompletedNCT01945086Phase 2Results posted
• Randomized Placebo Controlled Study to Determine Safety, Pharmacodynamics and Efficacy of ILV-094 in Atopic DermatitisCompletedNCT01941537Phase 2Results posted
• Efficacy and Safety Study of Desloratadine (MK-4117) in Japanese Participants With Eczema/Dermatitis and Dermal Pruritus (MK-4117-202)CompletedNCT01916980Phase 3Results posted
• A Randomized, Open-label, Comparative Study to Evaluate an Intermittent Dosing Regimen of Fluticasone Propionate 0.05% Cream (Twice Per Week) in Reducing the Risk of Relapse When Added to Regular Daily Moisturization Using PHYSIOGEL Lotion in Paediatric Subjects With Stabilized Atopic DermatitisCompletedNCT01915914Phase 4Results posted
• Blinded, Randomized Study Evaluating Aurstat Versus Control in the Treatment of Atopic Dermatitis Associated PruritusCompletedNCT01905631Phase 2Results posted
• Study of Dupilumab Administered to Adult Patients With Moderate-to-Severe Atopic DermatitisCompletedNCT01859988Phase 2Results posted
• Topical Roflumilast in Adults With Atopic DermatitisCompletedNCT01856764Phase 2Results posted
• A Confirmatory Study of TAU-284 in Pediatric Patients With Atopic DermatitisCompletedNCT01840605Phase 3Results posted
• Pilot Study of Ustekinumab for Subjects With Chronic Atopic DermatitisCompletedNCT01806662Phase 2Results posted
• Bioequivalence of Ethylenediamine Dihydrochloride StudyCompletedNCT01798589Phase 4Results posted
• Clinical Evaluation of T.R.U.E. Test Allergens in Children an AdolescentsCompletedNCT01797562Not applicableResults posted
• Efficacy and Safety Study of QAW039 in the Treatment of Patients With Moderate to Severe Atopic Dermatitis.CompletedNCT01785602Phase 2Results posted
• Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic DermatitisCompletedNCT01756898Phase 2Results posted
• Atopic Dermatitis Research Network (ADRN) Influenza Vaccine StudyCompletedNCT01737710Not applicableResults posted
• A Study of Intravenous MK-8226 in Participants With Moderate-to-Severe Atopic Dermatitis (MK-8226-003)TerminatedNCT01732510Phase 1Results posted
• Safety, Tolerability, and PK of AN2728 in Adolescents With Atopic DermatitisCompletedNCT01652885Phase 1/2Results posted
• Study to Assess the Safety of Dupilumab (REGN668/SAR231893) Administered Concomitantly With Topical Corticosteroids (TCS) in Patients With Moderate-to-severe Atopic Dermatitis (AD)CompletedNCT01639040Phase 2Results posted
• Efficacy and Safety of AN2728 Topical Ointment to Treat Adolescents With Atopic DermatitisCompletedNCT01602341Phase 2Results posted
• Daily Use of Lipikar Balm AP From Birth in Infants at High Risk of Developing Atopic DermatitisTerminatedNCT01577628Not applicableResults posted
• Study of Dupilumab in Adult Patients With Extrinsic Moderate-to-Severe Atopic DermatitisCompletedNCT01548404Phase 2Results posted
• A Phase 1, Randomized, Placebo-controlled, Dose-escalation Safety Study of MEDI4212 in Subjects With IgE >= 30 IU/mLCompletedNCT01544348Phase 1Results posted
• A Randomized, Double-blinded Placebo-controlled Study to Investigate Antimicrobial Efficacy and Safety Following Topical Application of DPK-060CompletedNCT01522391Phase 1/2Results posted

← Dermatitis overview